- Conditions: Prediabetes; Prehypertension
Intervention: Behavioral: Health Coaching
Sponsors: Memorial University of Newfoundland; Marshal Godwin; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified October 2011 - Condition: Influenza
Interventions: Biological: High Dose Trivalent Inactivated Influenza Vaccine; Biological: Trivalent Inactivated Influenza Vaccine
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Active, not recruiting - verified February 2012 - Condition: Gout
Intervention: Drug: Arhalofenat4e
Sponsors: Metabolex; Metabolex
Active, not recruiting - verified November 2011 - Conditions: Influenza, Human; Seasonal Influenza
Interventions: Biological: Quadrivalent seasonal influenza vaccine GSK2282512A; Biological: Fluarix®; Biological: Fluarix-YB; Biological: Quadrivalent seasonal influenza vaccine GSK2282512A
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified August 2011 - Condition: Meningococcal Infections
Interventions: Biological: Meningococcal vaccine GSK 134612; Biological: Menactra®
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified June 2011 - Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A; Biological: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Influenza Infection
Interventions: Biological: GSK2340274A; Biological: GSK2340273A
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified April 2011 - Condition: Influenza Infection
Interventions: Biological: GSK2340274A; Biological: GSK2340273A
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified January 2012 - Conditions: Psoriasis; Atopic Dermatitis
Interventions: Other: Blood pressure; Other: Height; Other: Weight; Other: BMI; Other: Waist Circumference
Sponsors: Northwestern University; Northwestern University
Recruiting - verified September 2011 - Conditions: Smoking Cessation; Insurance Coverage
Interventions: Other: Full Smoking Cessation Treatment Coverage (100%); Other: No Smoking Cessation Treatment Coverage (0%)
Sponsors: Pfizer; Pfizer
Completed - verified February 2012 - Condition: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Intervention: Biological: GSK580299, GSK Biological's HPV vaccine
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified April 2012 - Condition: Influenza Virus
Interventions: Biological: GSK Biologicals' influenza vaccine GSK1557482A; Biological: Vaxigrip
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified November 2011 - Condition: Contraception
Interventions: Drug: Qlaira (BAY86-5027, SH T00658ID); Drug: Ortho Tri Cyclen Lo
Sponsors: Bayer; Bayer
Completed - verified July 2011 - Condition: Influenza Disease
Interventions: Biological: GSK Bio's influenza vaccine GSK2186877A; Biological: Fluarix TM
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified January 2012 - Conditions: Cervical Cancer; Papillomavirus Infection
Intervention: Biological: GSK Bio's HPV vaccine 580299 (Cervarix TM)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified November 2011 - Conditions: Human Papillomavirus (HPV) Infection; Cervical Neoplasia
Interventions: Biological: Cervarix™; Biological: Havrix™-based investigational formulation
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified February 2012 - Condition: Papillomavirus Infection
Intervention: Biological: HPV 16/18 VLP AS04
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified October 2011 - Condition: Leukemia
Interventions: Drug: asparaginase; Drug: busulfan; Drug: cyclophosphamide; Drug: cyclosporine; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: etoposide; Drug: gemtuzumab ozogamicin; Drug: methotrexate; Drug: mitoxantrone hydrochloride; Procedure: allogeneic bone marrow transplantation
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Completed - verified November 2010 - Condition: Leukemia
Interventions: Biological: filgrastim; Drug: asparaginase; Drug: cyclophosphamide; Drug: cyclosporine; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: dexamethasone; Drug: etoposide; Drug: ifosfamide; Drug: imatinib mesylate; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: pegaspargase; Drug: vincristine sulfate; Procedure: allogeneic bone marrow transplantation; Procedure: peripheral blood stem cell transplantation; Procedure: umbilical cord blood transplantation; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Completed - verified November 2010
 |
Join Clinical Trials for Healthy Volunteers in Newfoundland and Labrador |
